Pulmont 5 mg (Chewable Tablet)

Unit Price: ৳ 8.00 (3 x 10: ৳ 240.00)
Strip Price: ৳ 80.00

Medicine Details

Category Details
Generic Montelukast sodium
Company Nuvista pharma ltd
Also available as
Pulmont 10 mg tablet

Title

  • Pulmont 5 mg Chewable Tablet

Categories

  • Medicine
  • Healthcare
  • Pharmaceuticals

Description

  • Pulmont is indicated for prophylaxis and chronic treatment of asthma, acute prevention of Exercise-Induced Bronchoconstriction (EIB), relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis
  • Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor, which is correlated with the pathophysiology of asthma & allergic rhinitis
  • Dosage for adults and adolescents 15 years of age and older: Montelukast 10 mg tablet once daily, for pediatric patients 6 to 14 years of age: Montelukast 5 mg tablet once daily, for pediatric patients 2 years to 5 years of age: Montelukast 4 mg tablet once daily, for pediatric patients 6 months to 5 years of age: Montelukast 4 mg oral granules once daily
  • Pulmont has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no apparent increase in adverse reactions; in drug interaction studies, it did not have clinically important effects on the pharmacokinetics of certain drugs
  • Common side effects include diarrhea, fever, gastrointestinal discomfort, headache, nausea, vomiting, and upper respiratory tract infection
  • Montelukast crosses the placenta following oral dosing in rats and rabbits, caution should be exercised when given to a nursing mother
  • Pulmont is not indicated for use in the reversal of bronchospasm in acute asthma attacks and should not be abruptly substituted for inhaled or oral corticosteroids
  • No adverse experiences in the majority of overdosage reports; abdominal pain, somnolence, thirst, headache, vomiting, and psychomotor hyperactivity were the most frequently occurring adverse experiences
  • Leukotriene receptor antagonists are the therapeutic class of Pulmont
  • Store in a cool & dry place below 30°C, protect from light & moisture, keep out of reach of children

Indications

  • Prophylaxis and chronic treatment of asthma
  • Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
  • Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis

Pharmacology

  • Selective and orally active leukotriene receptor antagonist
  • Inhibits the cysteinyl leukotriene receptor (CysLT1)
  • Correlated with the pathophysiology of asthma & allergic rhinitis
  • Inhibits cysteinyl leukotrienes and leukotriene receptor occupation

Dosage and administration

  • Adults and adolescents:
    • Montelukast 10 mg tablet once daily
  • Pediatric patients:
    • 6 to 14 years of age: Montelukast 5 mg tablet once daily
    • 2 years to 5 years of age: Montelukast 4 mg tablet once daily
    • 6 months to 5 years of age: Montelukast 4 mg oral granules once daily (directly in the mouth or mixed with cold water or soft food at room temperature)
  • Hepatic insufficiency: No dosage adjustment required in patients with mild-to-moderate hepatic insufficiency
  • Renal insufficiency: No dosage adjustment recommended in patients with renal insufficiency
  • Elderly use:
    • The pharmacokinetic profile and oral bioavailability of a single 10-mg oral dose of montelukast are similar in elderly and younger adults
    • No dosage adjustment required

Interaction

  • Administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no increase in adverse reactions
  • No clinically important effects on the pharmacokinetics of theophylline, prednisone, prednisolone, oral contraceptives, terfenadine, digoxin, and warfarin
  • Used concomitantly with a wide range of commonly prescribed drugs in clinical studies without clinical adverse interactions

Contraindications

  • Hypersensitivity to any component of this product

Side effects

  • Common:
    • Diarrhea
    • Fever
    • Gastrointestinal discomfort
    • Headache
    • Nausea
    • Vomiting
    • Upper respiratory tract infection
  • Uncommon:
    • Akathisia
    • Anxiety
    • Arthralgia
    • Asthenia
    • Abnormal behavior
    • Depression
    • Dizziness
    • Drowsiness
    • Dry mouth
    • Haemorrhage
    • Irritability
    • Malaise
    • Muscle complaints
    • Edema
    • Seizure
    • Abnormal sensation
    • Sleep disorders
  • Rare:
    • Angioedema
    • Impaired concentration
    • Disorientation
    • Eosinophilic granulomatosis with polyangiitis
    • Erythema nodosum
    • Hallucination
    • Hepatic disorders
    • Memory loss
    • Palpitations
    • Pulmonary eosinophilia
    • Suicidal tendencies
    • Tremor

Pregnancy and lactation

  • Caution should be exercised in pregnant women, use only if clearly needed
  • Caution should be exercised when given to a nursing mother

Precautions and warnings

  • Not indicated for use in the reversal of bronchospasm in acute asthma attacks
  • Appropriate rescue medication should be available
  • Therapy can be continued during acute exacerbations of asthma
  • Pulmont should not be abruptly substituted for inhaled or oral corticosteroids
  • Not to be used as monotherapy for the treatment and management of exercise-induced bronchospasm
  • Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents

Overdose effects

  • No adverse experiences in the majority of overdosage reports
  • Adverse experiences may include abdominal pain, somnolence, thirst, headache, vomiting, and psychomotor hyperactivity
  • Usual supportive measures should be employed in the event of overdose

Therapeutic class

  • Leukotriene receptor antagonists

Storage conditions

  • Store in cool & dry place below 30°C
  • Protect from light & moisture
  • Keep out of reach of children

Chemical structure

  • Molecular formula: C35H36ClNO3S
  • Chemical structure image: https://medex.com.bd/storage/res/g-res-768-montelukast-sodium-chemical-structure-drK1lRHjspWQ7613gJoZ.svg

Commonly asked questions

  • What is Pulmont 5 mg Chew. Tablet?
  • What is Pulmont 5 mg Chew. Tablet used for?
  • How soon can the effect of Pulmont 5 mg Chew. Tablet be observed?
  • How long does the effect of Pulmont 5 mg Chew. Tablet last?
  • Should I use Pulmont 5 mg Chew. Tablet empty stomach?
  • What if I miss a dose of Pulmont 5 mg Chew. Tablet?
  • Are there any pregnancy warnings for Pulmont 5 mg Chew. Tablet?
  • General Instructions: Take Pulmont 5 mg Chew. Tablet exactly as prescribed by your doctor, Do not change your Pulmont 5 mg Chew. Tablet dose or stop using asthma medication without your doctor's advice, Pulmont 5 mg Chew. Tablet is not a fast-acting rescue medicine for asthma attacks. Seek medical attention if your breathing problems get worse quickly, or if you think your medications are not working, Avoid situations or activities that may trigger an asthma attack, Talk to your doctor before using Pulmont 5 mg Chew. Tablet if you're pregnant or breastfeeding. They can help you decide if it's the right choice for you

Related Brands